Abstract
AbstractPer- and polyfluorinated alkyl substances (PFAS) are ubiquitous in most environments, accumulate in several tissues, and can adversely affect human health. PFAS have been implicated in neurodegenerative and behavioral disorders. However, the mechanisms through which PFAS affects biological function in neurons mostly remain unknown. In this study, SH-SY5Y neuroblastoma cells were used to study the effect of perfluorooctanoic acid (PFOA), perfluorooctansulfonic acid (PFOS), perfluorodecanoic acid (PFDA), perfluorodecanesulfonic acid (PFDS), 8:2 fluorotelomer sulfonate (8:2 FTS) and 8:2 fluorotelomer alcohol (8:2 FTOH) exposures on neuronal health. After a 30 μM-, 24-hour exposure, cells accumulated up to 800 ng PFAS/mg protein. Transcriptomics analysis of control and PFAS-exposed cells revealed 721 genes were differentially expressed across six treatments (padj< 0.05). Eleven of these differentially expressed genes were observed for all treatments, suggesting that these genes are potential markers for neuronal PFAS exposure. In PFOA-treated cells, we observed multiple downregulated genes are enriched for functions related to synaptic growth and neural function. In contrast, upregulated genes in PFOS, PFDS, FTS, and FTOH-treated cells showed enrichment in functions related to response to hypoxia and amino acid metabolism, suggesting PFAS impact different cellular processes in neuronal cells based on their chemical composition and structure. Consistent with this observation, analysis of major lipid classes after exposure to select PFAS showed significant upregulation of fatty acids with PFDA, PFDS and 8:2 FTS and downregulation of triacylglycerols with 8:2 FTOH exposure. Overall, these results suggest that PFAS induce different effectsin vitrodepending on their chemical structures and specific biological processes that potentially underlie negative effects of PFAS on neuronal health.SynopsisPer- and poly fluorinated alkyl substances (PFAS) have been shown to bioaccumulate in human tissues and affect health. This study aims to provide insight into the specific biological processes by which PFAS exposure affects neuronal cells.
Publisher
Cold Spring Harbor Laboratory
Reference78 articles.
1. Serum Biomarkers of Exposure to Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of Thyroid Function among Adults and Adolescents from NHANES 2011–2012
2. Shu, H. ; Lindh, C. H. ; Wikström, S. ; Bornehag, C.-G. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study. PLOS ONE 2019, 13 (12).
3. Time Trends in Per- and Polyfluoroalkyl Substances (PFASs) in California Women: Declining Serum Levels, 2011–2015
4. Multi-Industry Per- and Polyfluoroalkyl Substances (PFAS) Study – 2021 Preliminary Report. Agency, U. S. E. P. , Ed.; 1200 Pennsylvania Avenue, NW Washington, DC 20460, 2021.
5. Identification and classification of commercially relevant per‐ and poly‐fluoroalkyl substances (PFAS)